|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Leonessa F and Clarke R: ATP binding
cassette transporters and drug resistance in breast cancer. Endocr
Relat Cancer. 10:43–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kliewer SA, Moore JT, Wade L, et al: An
orphan nuclear receptor activated by pregnanes defines a novel
steroid signaling pathway. Cell. 92:73–82. 1998. View Article : Google Scholar
|
|
4
|
Minemura M, Tanimura H and Tabor E:
Overexpression of multidrug resistance genes MDR1 and cMOAT in
human hepatocellular carcinoma and hepatoblastoma cell lines. Int J
Oncol. 15:559–563. 1999.PubMed/NCBI
|
|
5
|
Tolson AH and Wang H: Regulation of
drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv
Drug Deliv Rev. 62:1238–1249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen T: Overcoming drug resistance by
regulating nuclear receptors. Adv Drug Deliv Rev. 62:1257–1264.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Campa D, Butterbach K, Nieters A, et al: A
comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2,
NR1I2 genes and lymphoma risk. Int J Cancer. 131:803–812. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heid CA, Stevens J, Livak KJ and Williams
PM: Real time quantitative PCR. Genome Res. 6:986–994. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mellor HR and Callaghan R: Resistance to
chemotherapy in cancer: a complex and integrated cellular response.
Pharmacology. 81:275–300. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Navarro G, Sawant RR, Biswas S, Essex S,
Tros de Ilarduya C and Torchilin VP: P-glycoprotein silencing with
siRNA delivered by DOPE-modified PEI overcomes doxorubicin
resistance in breast cancer cells. Nanomedicine (Lond). 7:65–78.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan JH, Cheng JQ, Zhuang ZX, et al: Study
on the relationship between breast cancer resistance protein
expression and 5-fluorouracil resistance. Zhonghua Yu Fang Yi Xue
Za Zhi. 42:506–510. 2008.(In Chinese).
|
|
12
|
Liu X, Chen P, Cui J and Zhang G:
Expression of drug resistance related proteins in breast cancer
tissues and its relationship with chemotherapy therapeutic effect.
Chin J Cancer Prev Treatment. 18:1354–1357. 2011.
|
|
13
|
Chen Y, Nie D, Wang MT, et al: Human
pregnane X receptor and resistance to chemotherapy in prostate
cancer. Cancer Res. 67:10361–10367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raynal C, Evrard A, Kantar J, et al:
Pregnane X receptor (PXR) expression in colorectal cancer cells
restricts irinotecan chemosensitivity through enhanced SN-38
glucuronidation. Mol Cancer. 9:462010. View Article : Google Scholar
|
|
15
|
Dotzlaw H, Leygue E, Watson P and Murphy
LC: The human orphan receptor PXR messenger RNA is expressed in
both normal and neoplastic breast tissue. Clin Cancer Res.
5:2103–2107. 1999.
|
|
16
|
Conde I, Lobo MV, Zamora J, et al: Human
pregnane X receptor is expressed in breast carcinomas, potential
heterodimers formation between hPXR and RXR-alpha. BMC Cancer.
8:1742008. View Article : Google Scholar
|
|
17
|
Meyer zu Schwabedissen HE, Tirona RG, Yip
CS, et al: Interplay between the nuclear receptor pregnane X
receptor and the uptake transporter organic anion transporter
polypeptide 1A2 selectively enhances estrogen effects in breast
cancer. Cancer Res. 68:9338–9347. 2008.
|
|
18
|
Chen Y, Tang Y, Chen S and Nie D:
Regulation of drug resistance by human pregnane X receptor in
breast cancer. Cancer Biol Ther. 8:1265–1272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang H, Chen W, Chen K, He J and Liang H:
Roles of pregnane X receptor for proliferation and drug resistance
in human colon cancer cells. Prog Mod Biomed. 9:2012–2015.
2009.
|
|
20
|
Honorat M, Mesnier A, Di Pietro A, et al:
Dexamethasone down-regulates ABCG2 expression levels in breast
cancer cells. Biochem Biophys Res Commun. 375:308–314. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Masuyama H, Nakatsukasa H, Takamoto N and
Hiramatsu Y: Down-regulation of pregnane X receptor contributes to
cell growth inhibition and apoptosis by anticancer agents in
endometrial cancer cells. Mol Pharmacol. 72:1045–1053. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Venkatesh M, Li H, et al: Pregnane
X receptor activation induces FGF19-dependent tumor aggressiveness
in humans and mice. J Clin Invest. 121:3220–3232. 2011. View Article : Google Scholar
|
|
23
|
Liu C, Li J, Wang L, et al: Analysis of
tanshinone IIA induced cellular apoptosis in leukemia cells by
genome-wide expression profiling. BMC Complement Altern Med.
12:52012. View Article : Google Scholar : PubMed/NCBI
|
